Average Co-Inventor Count = 5.78
ph-index = 18
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Blueprint Medicines Corporation (35 from 60 patents)
2. Amgen Inc. (19 from 1,974 patents)
3. Vertex Pharmaceuticals, Inc. (6 from 1,151 patents)
60 patents:
1. 12448379 - Wild type kit inhibitors
2. 12172983 - EGFR inhibitors
3. 12042495 - MAP4K1 inhibitors
4. 11970498 - CDK2 inhibitors
5. 11932648 - CDK2 inhibitors
6. 11827642 - Compositions useful for treating disorders related to KIT
7. 11718602 - EGFR inhibitors
8. 11634422 - Inhibitors of activin receptor-like kinase
9. 11534441 - MAP4K1 inhibitors
10. 11279688 - Inhibitors of RET
11. 11261497 - PRKC fusions
12. 11236086 - Substituted pyrrolopyridines as inhibitors of activin receptor-like kinase
13. 11059827 - Compounds and compositions useful for treating disorders related to NTRK
14. 11040979 - Substituted pyrrolo[1,2-b]pyridazines for treating disorders related to KIT and PDGFR
15. 10875930 - PIK3C2G fusions